Drug Profile
Research programme: antibody based thererapeutics - Denceptor Therapeutics
Alternative Names: E6/E7 immunotherapy; HPV immunotherapyLatest Information Update: 07 Nov 2021
Price :
$50
*
At a glance
- Originator Denceptor Therapeutics
- Class Antibodies; Recombinant proteins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders; Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Autoimmune-disorders in United Kingdom (Parenteral)
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in United Kingdom (Parenteral)
- 14 Jul 2016 Early research in Autoimmune disorders in United Kingdom (Parenteral)